Evidence map›Paper›PMID 36112130›Full record

Observational studyActa anaesthesiologica Scandinavica2023

Trajectory of plasma syndecan-1 and heparan sulphate during major surgery: A retrospective observational study.

Laurence Weinberg, Fumitaka Yanase, Shervin Tosif, Bernhard Riedel, Rinaldo Bellomo, Robert G Hahn

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Acta anaesthesiologica Scandinavica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laurence WeinbergDepartment of Anaesthesia, Austin Hospital, Melbourne, Australia.ORCID 0000-0001-7403-7680
Fumitaka YanaseDepartment of Intensive Care, Austin Hospital, Melbourne, Australia.
Shervin TosifDepartment of Anaesthesia, Austin Hospital, Melbourne, Australia.
Bernhard RiedelDepartment of Critical Care, The University of Melbourne, Melbourne, Australia.
Rinaldo BellomoDepartment of Critical Care, The University of Melbourne, Melbourne, Australia.
Robert G HahnKarolinska Institute at Danderyd's Hospital (KIDS), Stockholm, Sweden.ORCID 0000-0002-1528-3803
The University of Melbourne · AUAustin Hospital · AUKarolinska Institutet · SE

Funding

Council of Australian University Librarians
6 · The paper itself

Abstract

backgroundSurgical trauma-induced inflammation during major surgery may disrupt endothelial integrity and affect plasma concentrations of glycocalyx constituents, such as syndecan-1 and heparan sulphate. To date, no studies have focused on their perioperative temporal changes.

methodsAs part of a trial, we obtained plasma and urine specimens sampled during the perioperative period in 72 patients undergoing major abdominal surgery. The plasma concentration of syndecan-1 and heparan sulphate was measured on five occasions, from baseline to the second postoperative day. Plasma and urinary creatinine and urinary syndecan-1 concentrations were measured before surgery and on the first postoperative morning.

resultsWe observed three different temporal patterns of plasma syndecan-1 concentration. Group 1 'low' (64% of patients) showed only minor changes from baseline despite a median heparan sulphate increase of 67% (p < .005). Group 2 'increase' (21% of patients) showed a marked increase in median plasma syndecan-1 from 27 μg/L to 118 μg/L during the first postoperative day (p < .001) with a substantial (+670%; p < .005) increase in median plasma heparan sulphate from 279 to 2196 μg/L. Group 3 'high' (14% of patients) showed a constant elevation of plasma syndecan-1 to >100 μg/L, but low heparan sulphate levels. The plasma C-reactive protein concentration did not differ across the three groups and 90% of colon surgeries occurred in Group 1. Treatment with dexamethasone was similar across the three groups. Surgical blood loss, duration of surgery and liver resection were greatest in Group 2.

conclusionChanges in syndecan-1 and heparan sulphate after surgery appear to show three different patterns, with the greatest increases in those patients with greater blood loss, more liver surgery and longer operations. These observations suggest that increases in syndecan-1 and heparan sulphate reflect the degree of surgical injury.

Indexed as

LiverSyndecan-1GlycocalyxHeparan SulfateHumansInflammationRetrospective StudiesHeparan SulfateSyndecan-1anaesthesiafluidsglycocalyxinflammationsurgery

Identifiers

PMID36112130
PMCPMC10087164
OpenAlexW4296036476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.